Tumorerkrankungen

Basalzell-Naevus-Syndrom (Gorlin-Syndrom), ID 806.00 (3 Gene)

---

Bekannte EGFR aktivierende Mutationen in Exons 18-21, ID 1003.00 (1 Gene)

---

CUP - Cancer of unknown primary, ID 847.00 (8 Gene)

---

Erbliche Tumorerkrankungen, umfassende Diagnostik, ID 093.04 (172 Gene)

---

Exostosis multiplex (EXT1, EXT2) (1 Gene)

---

FLCN Birt-Hogg-Dube Syndrom (1 Gene)

---

Gorlin-Syndrom (PTCH1, SUFU, PTCH2) (3 Gene)

---

Hereditäre Leukämien, ID 998.00 (17 Gene)

---

Leiomyomatose (FH) (1 Gene)

---

LiFraumeni-Syndrom (TP53, CHEK2) (2 Gene)

---

Liquid Biopsy AKT-Inhibitoren, ID 940.00 (1 Gene)

---

Liquid Biopsy Aromatase-Inhibitoren, ID 946.00 (1 Gene)

---

Liquid Biopsy BRAF-MEK-Inhibitoren, ID 943.00 (1 Gene)

---

Liquid Biopsy Cholangiokarzinom, ID 949.00 (1 Gene)

---

Liquid Biopsy Kolorektales Karzinom, ID 950.00 (4 Gene)

---

Liquid Biopsy Mammakarzinom, ID 948.00 (4 Gene)

---

Liquid Biopsy MET-Inhibitoren, ID 956.00 (1 Gene)

---

Liquid Biopsy nicht-kleinzelliger Lungenkrebs, ID 947.00 (11 Gene)

---

Liquid Biopsy PARP-Inhibitoren, ID 939.00 (2 Gene)

---

Liquid Biopsy PI3K-Inhibitoren, ID 938.00 (1 Gene)

---

Liquid Biopsy PI3K-Inhibitoren, ID 1002.00 (1 Gene)

---

Liquid Biopsy Prostatakarzinom, ID 951.00 (5 Gene)

---

Liquid Biopsy PTEN, ID 941.00 (1 Gene)

---

Liquid Biopsy Schilddrüsenkarzinom, ID 953.00 (2 Gene)

---

Liquid Biopsy TKI-EGFR-Inhibitoren, ID 945.00 (1 Gene)

---

Liquid Biopsy TKI-HER2-Inhibitoren, ID 942.00 (1 Gene)

---

Liquid Biopsy Tumor, ID 954.00 (27 Gene)

---

Liquid Biopsy Urothelkarzinom, ID 952.00 (4 Gene)

---

Liquid Biopsy VEGF- und EGFR-Inhibitoren, ID 944.00 (3 Gene)

---

Lungenkarzinom, ID 958.00 (7 Gene)

---

Malignes Melanom, ID 705.01 (15 Gene)

---

Neuroblastom, ID 960.00 (15 Gene)

---

Neurofibromatose / Schwannomatose, ID 704.00 (5 Gene)

---

PreCan, ID 921.00 (70 Gene)

---

PreCan+, ID 935.00 (70 Gene)

---

Tuberöse Sklerose, ID 805.00 (2 Gene)

---